Format

Send to

Choose Destination
Rev Med Inst Mex Seguro Soc. 2017;55(Suppl 2):S118-23.

Global burden of disease of chronic kidney disease in Mexico

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
División de Hospitales, Coordinación de Atención integral en Segundo Nivel, Instituto Mexicano del Seguro Social, Ciudad de México, México Correo electrónico: marisol.torrest@imss.gob.mx

Abstract

in English, Spanish

The Global Burden of Disease (GBD) is a methodology that evaluates risks to the population risks when confronted with a disease or injury, such as the entirety of the effects of mortality and disability that these represent for health systems. The chronic kidney disease (CKD) is an entity with high mortality, high disability, and high health-intervention costs. The review of the data generated by the Institute for Health Metrics and Evaluation (IHME), the headquarters of the GBD Study Group, show that at worldwide level, CKD-associated mortality has increased 108% since 1990 to 2015. The main cause that generates death by CKD in Mexico is diabetes mellitus, whose impact on mortality has progressed, being found in 19th place for diabetic nephropathy in 1990 to the 3rd cause of death in 2015, representing a 670% increase. Ages with greatest mortality are situated between 45 and 75 years, generating a greater impact on disability-adjusted death in women. Mexico City has the greatest CKD-related mortality and a greatest number of DALY (Disability-Adjusted Life Years): 1,559.71 per 100 000 inhabitants. The Mexican state with the lower number of deaths is Baja California, and Quintana Roo is the state with the lower number of DALY (766.32 per 100 000 inhabitants).

KEYWORDS:

Cost of Illness; Renal Insufficiency, Chronic; Mexico

PMID:
29697221
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center